The FDA approved Hepcludex (bulevirtide-gmod), the first treatment for chronic hepatitis delta virus (HDV) in adults with or without compensated cirrhosis. Clinical trials showed significantly higher...
Moroccan airports handled 36.3 million passengers in 2025, up 11%, driven by strong international traffic and recovering domestic travel. Aircraft movements rose 9% and freight reached...
Bitcoin rebounds to $77K amid ETF outflows, SEC-approved index options uncertainty, and weak market sentiment, while Ethereum faces sustained ETF withdrawals and governance debate. Altcoins show...
ESG strategies in fashion can cut costs, boost revenues, and strengthen brands, yet attention is declining amid AI focus, weak growth, and geopolitical pressures. Climate change...
AI is rapidly expanding, raising job fears and bubble concerns. Michael Burry warns of an AI-driven market bubble led by major tech stocks. Like past tech...
The Dow Jones hadn’t made a new all-time high since last February, as many of the major stock indexes I follow, have made multiple new all-time...
Fellow affiliates. This week, we’re going to talk about three big IPO events that are coming up. Why? Because each one of them is a big...
BICICI, majority owned by a state-linked consortium, posted a 17.1% rise in net banking income in Q1 2026 to 21.214 billion FCFA, driven by stronger margins...
Roche Pharma invested €57 million in Spain in 2025, running 283 clinical trials on 76 molecules with 8,584 patients and 950 researchers across 178 centers. Trials...
Germany’s medical cannabis market is expanding, with over 50 tons imported in early 2026, making it Europe’s leading market. Reforms improved patient access and boosted demand,...